Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
16385 studies found for:    ( NOT NOTEXT ) [FIRST-RECEIVED-RESULTS-DATE]
Show Display Options
RSS Create an RSS feed from your search for:
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Evaluation of S-adenosyl Methionine (SAM-e) for Recurrent Abdominal Pain in Children
Condition: Abdominal Pain
Intervention: Drug: S-adenosyl methionine
2 Completed
Has Results
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ranolazine;   Drug: Placebo to match ranolazine;   Drug: Metformin;   Drug: Placebo to match metformin;   Behavioral: Diet;   Behavioral: Exercise
3 Terminated
Has Results
Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy
Condition: Colorectal Cancer
Interventions: Drug: everolimus;   Procedure: antiangiogenesis therapy;   Procedure: biopsy;   Procedure: diagnostic procedure;   Procedure: gene expression analysis;   Procedure: immunohistochemistry staining method;   Procedure: laboratory biomarker analysis;   Procedure: mutation analysis;   Procedure: protein tyrosine kinase inhibitor therapy;   Procedure: reverse transcriptase-polymerase chain reaction
4 Completed
Has Results
Encouraging Healthy Food Shopping and Eating Behaviors by Price Reduction: A Community Supermarket Study
Condition: Obesity
Intervention: Behavioral: Discount intervention
5 Completed
Has Results
Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension
Conditions: Open-angle Glaucoma;   Ocular Hypertension
Interventions: Drug: 0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution;   Drug: 0.03% Bimatoprost Ophthalmic Solution and 0.5% Timolol Ophthalmic Solution
6 Completed
Has Results
Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer
Condition: Carcinoma, Renal Cell
Intervention: Drug: pazopanib
7 Completed
Has Results
Lapatinib in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer;   Neoplasms, Breast
Interventions: Drug: Lapatinib;   Drug: capecitabine
8 Completed
Has Results
Obesity and Nonalcoholic Fatty Liver Disease
Condition: Non-Alcoholic Fatty Liver Disease
Interventions: Drug: Niacin;   Drug: fenofibrate;   Drug: placebo
9 Completed
Has Results
A Study to Evaluate Efficacy and Safety of Four Posaconazole Regimens With Placebo and Terbinafine in the Treatment of Toenail Onychomycosis (Study P05082AM2)(COMPLETED)
Condition: Onychomycosis
Interventions: Drug: SCH 56592;   Drug: Terbinafine;   Drug: Placebo
10 Completed
Has Results
Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED)
Conditions: Ocular Hypertension;   Open Angle Glaucoma
Intervention: Drug: dorzolamide hydrochloride (+) timolol maleate
11 Completed
Has Results
Phenytoin and Multidose Activated Charcoal
Condition: Phenytoin Toxicity
Intervention: Drug: Activated Charcoal
12 Completed
Has Results
A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937)
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: Asenapine 3x5mg followed by 1x15mg;   Drug: Asenapine 1x15mg followed by 3x5mg
13 Completed
Has Results
Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients
Conditions: Multidrug-resistant Tuberculosis;   Extensively Drug-resistant Tuberculosis
Intervention: Drug: Addition of different doses of clarithromycin.
14 Completed
Has Results
A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis
Conditions: Vaginitis;   Infectious Vaginosis
Interventions: Drug: Gynoclin V;   Drug: Vagitrol V
15 Completed
Has Results
Comparison of the Effect of Vytorin 10/80 Tablet Split Into 4 and Simvastatin 20 Milligrams on Low-density Lipoprotein (LDL) Cholesterol
Condition: Hypercholesterolemia
Interventions: Drug: Vytorin;   Drug: Simvastatin
16 Completed
Has Results
Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population
Condition: Asthma
Interventions: Drug: Fluticasone propionate;   Drug: Budesonide;   Drug: Montelukast
17 Completed
Has Results
Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children
Conditions: Japanese Encephalitis;   Hepatitis A
Interventions: Biological: Japanese encephalitis vaccine (Day 0) Hepatitis A vaccine (Day 28);   Biological: Hepatitis A vaccine (Day 0) Japanese encephalitis vaccine (Day 28)
18 Completed
Has Results
Bortezomib in Treating Patients With Lymphoproliferative Disorders
Conditions: Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma
Intervention: Drug: bortezomib
19 Completed
Has Results
Sodium Oxybate in Patients With Alternating Hemiplegia of Childhood (AHC-SO)
Condition: Alternating Hemiplegia of Childhood
Intervention: Drug: Sodium Oxybate
20 Completed
Has Results
Observational Study to Evaluate the Current Neuromuscular Monitoring Practice Used After Different Types of Surgery, for Which Neuromuscular Blocking Agents Were Used, With or Without Blocking Reversal (P06556)
Condition: Neuromuscular Monitoring After Administration of Neuromuscular Blocking Agents in Different Types of Surgery
Interventions: Other: No neuromuscular blockade (NMB)-reversal agent used;   Drug: Sugammadex;   Drug: Other NMB-Reversal Agents Used in Routine Anesthesiology Practice

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years